We are excited to collaborate with Biogen on litifilimab,” said Pablo Legorreta, Royalty Pharma’s founder and Chief Executive Officer. “Royalty Pharma offers tailored, win-win funding solutions for ...

Fidelity Growth Company Fund's Retail Class (FDGRX) shares gained 7.52%, outpacing the benchmark.Click here to read the full ...

Validus Risk Management, a software services platform for financial risk management, announced that it has secured growth ...

Despite challenges in the RV market, REV Group's specialty vehicles segment has driven strong earnings, leading to a 74.27% ...

Resolute Capital Partners announced Monday that Tyler Augusty has been named partner and Erik Prochnow has been promoted to ...